GSK
About: In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Employees: 68,629
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
339% more call options, than puts
Call options by funds: $460M | Put options by funds: $105M
20% more funds holding in top 10
Funds holding in top 10: 10 [Q3] → 12 (+2) [Q4]
0.76% more ownership
Funds ownership: 7.48% [Q3] → 8.25% (+0.76%) [Q4]
7% less funds holding
Funds holding: 888 [Q3] → 825 (-63) [Q4]
9% less capital invested
Capital invested by funds: $12.7B [Q3] → $11.6B (-$1.08B) [Q4]
11% less repeat investments, than reductions
Existing positions increased: 281 | Existing positions reduced: 315
32% less first-time investments, than exits
New positions opened: 101 | Existing positions closed: 148
Research analyst outlook
We haven’t received any recent analyst ratings for GSK.
Financial journalist opinion
Based on 287 articles about GSK published over the past 30 days









